Strategy
Strategy - Indonesia Banks: Free-Float Compliance Faces A Valuation Hurdle
Analyst
Highlights
- Rp21.4t of potential supply across 26 banks, with 73% concentrated in five names. Shareholder reluctance to sell at weak valuations could delay execution. Large banks (≥Rp5t market cap) with less than 12.5% public float must hit 12.5% by 31 Mar 27, and 15.0% by 31 Mar 28. Small banks (<Rp5t cap) have until 31 Mar 29.
- BRIS’ proposed rights issue puts public demand in focus. The bank plans to issue up to 6.8b shares, implying 12.85% of ownership dilution for non-participating shareholders. The final size, pricing and major shareholders’ participation remain undisclosed.
- Be selective: Buy the deal, not the deadline. BNGA faces a pricing hurdle, BDMN’s integration could alter its float requirement, and BNLI has yet to disclose a preferred route.
What’s New
- Free-float deadline looms, but weak valuations could delay execution. Our screen shows 26 banks below 15% free float. Reaching 15% by shareholder selldown would need Rp21.4t of shares (closing prices, 28 Sep 26). This is a sizing exercise, not a placement forecast. Most of these banks do not need new equity, and their controlling shareholders have no reason to sell large blocks into a weak market. We expect bank-by-bank outcomes, not a simultaneous wave of sales. Investors will wait for terms, so the overhang caps the shares until deals are announced.
- The deadline creates an incentive for negotiations, not an immediate sale. Banks in the Rp5t+ market cap group with float below 12.5% at the reference date must reach 12.5% by 31 Mar 27 and 15% by 31 Mar 28. Issuers below Rp5t have until 31 Mar 29. We believe major shareholders are using the time available to seek better valuations, assess the cost of non-compliance, and discuss possible routes to compliance with the regulator. This could push transactions closer to the deadlines, particularly if market conditions remain weak. Bank Syariah Indonesia (BRIS) has formally proposed a rights issue, while Bank CIMB Niaga (BNGA) continues to assess its options. Bank Danamon’s (BDMN) approach may be shaped by the potential integration with MUFG Jakarta, and Bank Permata (BNLI) says it is working toward compliance but has not disclosed a preferred route.
- BRIS: The first live test and execution risk sits with public demand. BRIS’ disclosure confirms its proposed rights issue route, with up to 6.8b new shares and completion targeted for 1Q27, subject to shareholder approval at the 6 Nov 26 shareholder meeting. All net proceeds will support financing growth. Based on our calculation, the maximum issuance is approximately 2.2x the 3.08b new shares required to raise eligible float from 9.33% to exactly 15%, assuming all new shares enter eligible public ownership. Full issuance of 6.8b under that assumption would lift float to approximately 20.98% and dilute non-participating shareholders’ ownership by 12.85%.
- BRIS projects capital increasing from Rp51.1t in 2026 to Rp64.4t in 2027, (according to its rights issue disclosure), moving it closer to KBMI 4, with CAR increasing from 20.38% to 23.31%. Using Bloomberg consensus adjusted profit estimates and assuming a 20% payout of 2026 profit, paid in 2027, our simplified capital bridge suggests net fundraising of approximately Rp5.25t, before allowing for other regulatory-capital movements. This is our illustrative estimate; BRIS has not disclosed a fundraising target, final issuance size or subscription price. Our earlier management discussion suggested that the three major shareholders could waive fully or partially their subscription rights, although this has yet to be formally confirmed.
- Our illustrative Rp5.25t fundraising estimate is equivalent to approximately 8.0% of BRIS’ market capitalisation and 85.9% of its existing eligible free-float market value (total market cap: Rp65.5t). If the major shareholders do not fully participate or just partially participate, execution would depend on demand from existing public shareholders, new investors and any standby buyers. The larger potential public allocation could improve liquidity, but uncertainty over pricing and subscription commitments will weigh on the shares. We would not recommend increasing exposure before that.
Highlights
- Rp21.4t of potential supply across 26 banks, with 73% concentrated in five names. Shareholder reluctance to sell at weak valuations could delay execution. Large banks (≥Rp5t market cap) with less than 12.5% public float must hit 12.5% by 31 Mar 27, and 15.0% by 31 Mar 28. Small banks (<Rp5t cap) have until 31 Mar 29.
- BRIS’ proposed rights issue puts public demand in focus. The bank plans to issue up to 6.8b shares, implying 12.85% of ownership dilution for non-participating shareholders. The final size, pricing and major shareholders’ participation remain undisclosed.
- Be selective: Buy the deal, not the deadline. BNGA faces a pricing hurdle, BDMN’s integration could alter its float requirement, and BNLI has yet to disclose a preferred route.
What’s New
- Free-float deadline looms, but weak valuations could delay execution. Our screen shows 26 banks below 15% free float. Reaching 15% by shareholder selldown would need Rp21.4t of shares (closing prices, 28 Sep 26). This is a sizing exercise, not a placement forecast. Most of these banks do not need new equity, and their controlling shareholders have no reason to sell large blocks into a weak market. We expect bank-by-bank outcomes, not a simultaneous wave of sales. Investors will wait for terms, so the overhang caps the shares until deals are announced.
- The deadline creates an incentive for negotiations, not an immediate sale. Banks in the Rp5t+ market cap group with float below 12.5% at the reference date must reach 12.5% by 31 Mar 27 and 15% by 31 Mar 28. Issuers below Rp5t have until 31 Mar 29. We believe major shareholders are using the time available to seek better valuations, assess the cost of non-compliance, and discuss possible routes to compliance with the regulator. This could push transactions closer to the deadlines, particularly if market conditions remain weak. Bank Syariah Indonesia (BRIS) has formally proposed a rights issue, while Bank CIMB Niaga (BNGA) continues to assess its options. Bank Danamon’s (BDMN) approach may be shaped by the potential integration with MUFG Jakarta, and Bank Permata (BNLI) says it is working toward compliance but has not disclosed a preferred route.
- BRIS: The first live test and execution risk sits with public demand. BRIS’ disclosure confirms its proposed rights issue route, with up to 6.8b new shares and completion targeted for 1Q27, subject to shareholder approval at the 6 Nov 26 shareholder meeting. All net proceeds will support financing growth. Based on our calculation, the maximum issuance is approximately 2.2x the 3.08b new shares required to raise eligible float from 9.33% to exactly 15%, assuming all new shares enter eligible public ownership. Full issuance of 6.8b under that assumption would lift float to approximately 20.98% and dilute non-participating shareholders’ ownership by 12.85%.
- BRIS projects capital increasing from Rp51.1t in 2026 to Rp64.4t in 2027, (according to its rights issue disclosure), moving it closer to KBMI 4, with CAR increasing from 20.38% to 23.31%. Using Bloomberg consensus adjusted profit estimates and assuming a 20% payout of 2026 profit, paid in 2027, our simplified capital bridge suggests net fundraising of approximately Rp5.25t, before allowing for other regulatory-capital movements. This is our illustrative estimate; BRIS has not disclosed a fundraising target, final issuance size or subscription price. Our earlier management discussion suggested that the three major shareholders could waive fully or partially their subscription rights, although this has yet to be formally confirmed.
- Our illustrative Rp5.25t fundraising estimate is equivalent to approximately 8.0% of BRIS’ market capitalisation and 85.9% of its existing eligible free-float market value (total market cap: Rp65.5t). If the major shareholders do not fully participate or just partially participate, execution would depend on demand from existing public shareholders, new investors and any standby buyers. The larger potential public allocation could improve liquidity, but uncertainty over pricing and subscription commitments will weigh on the shares. We would not recommend increasing exposure before that.
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
